174 related articles for article (PubMed ID: 27493974)
61. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.
Dong X; Gong Y; Zeng H; Hao Y; Wang X; Hou J; Wang J; Li J; Zhu Y; Liu H; Han J; Zhou H; Shen L; Gao T; Zhou T; Yang S; Li S; Chen Y; Meng Q; Li H
Liver Int; 2013 Nov; 33(10):1517-26. PubMed ID: 23869954
[TBL] [Abstract][Full Text] [Related]
62. Circulating T-regulatory cells in PNET: a prospective study.
Tilak TV; Sharawat S; Gupta R; Agarwala S; Vishnubhatla S; Bakhshi S
Pediatr Blood Cancer; 2014 Feb; 61(2):228-32. PubMed ID: 23997029
[TBL] [Abstract][Full Text] [Related]
63. Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
Bailur JK; Gueckel B; Derhovanessian E; Pawelec G
Breast Cancer Res; 2015 Mar; 17(1):34. PubMed ID: 25849846
[TBL] [Abstract][Full Text] [Related]
64. Regulatory T cell subtypes and TGF-β1 gene expression in chronic allograft dysfunction.
Assadiasl S; Ahmadpoor P; Nafar M; Lessan Pezeshki M; Pourrezagholi F; Parvin M; Shahlaee A; Sepanjnia A; Nicknam MH; Amirzargar A
Iran J Immunol; 2014 Sep; 11(3):139-52. PubMed ID: 25266000
[TBL] [Abstract][Full Text] [Related]
65. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
[TBL] [Abstract][Full Text] [Related]
66. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].
Salgado C; Bladé J; López-Guillermo A; Cervantes F; Montserrat E; Rozman C
Sangre (Barc); 1993 Oct; 38(5):371-4. PubMed ID: 8140498
[TBL] [Abstract][Full Text] [Related]
67. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
Golombick T; Diamond TH; Manoharan A; Ramakrishna R
Am J Hematol; 2012 May; 87(5):455-60. PubMed ID: 22473809
[TBL] [Abstract][Full Text] [Related]
68. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
69. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
70. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
[TBL] [Abstract][Full Text] [Related]
71. [Abnormal quantity of regulatory T cells in peripheral blood of patients with severe aplastic anemia and its clinical significance].
Qi WW; Fu R; Wang HQ; Liu CY; Ren Y; Tao JL; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1043-6. PubMed ID: 25130825
[TBL] [Abstract][Full Text] [Related]
72. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
[TBL] [Abstract][Full Text] [Related]
73. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
74. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
75. Asymptomatic monoclonal gammopathies.
Bories C; Jagannath S
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S78-86. PubMed ID: 25486961
[TBL] [Abstract][Full Text] [Related]
76. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults.
Guerard EJ; Tuchman SA
Clin Geriatr Med; 2016 Feb; 32(1):191-205. PubMed ID: 26614868
[TBL] [Abstract][Full Text] [Related]
77. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
[TBL] [Abstract][Full Text] [Related]
78. Multiple Myeloma and the Immune Microenvironment.
Kawano Y; Roccaro AM; Ghobrial IM; Azzi J
Curr Cancer Drug Targets; 2017; 17(9):806-818. PubMed ID: 28201978
[TBL] [Abstract][Full Text] [Related]
79. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
[TBL] [Abstract][Full Text] [Related]
80. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
